Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy

The OVIVA study demonstrated noninferiority for managing bone and joint infections (BJIs) with oral antibiotics. We report that 79.7% of OPAT patients being treated for BJIs at our center would be eligible for oral antibiotics, saving a median (IQR) 19.5 IV-antibiotic days (8.5–37) and GBP 1234 (569...

Descripción completa

Detalles Bibliográficos
Autores principales: Marks, Michael, Bell, Lucy C K, Jones, Imogen, Rampling, Tommy, Kranzer, Katharina, Morris-Jones, Stephen, Logan, Sarah, Pollara, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312207/
https://www.ncbi.nlm.nih.gov/pubmed/31603189
http://dx.doi.org/10.1093/cid/ciz991
_version_ 1783549680094806016
author Marks, Michael
Bell, Lucy C K
Jones, Imogen
Rampling, Tommy
Kranzer, Katharina
Morris-Jones, Stephen
Logan, Sarah
Pollara, Gabriele
author_facet Marks, Michael
Bell, Lucy C K
Jones, Imogen
Rampling, Tommy
Kranzer, Katharina
Morris-Jones, Stephen
Logan, Sarah
Pollara, Gabriele
author_sort Marks, Michael
collection PubMed
description The OVIVA study demonstrated noninferiority for managing bone and joint infections (BJIs) with oral antibiotics. We report that 79.7% of OPAT patients being treated for BJIs at our center would be eligible for oral antibiotics, saving a median (IQR) 19.5 IV-antibiotic days (8.5–37) and GBP 1234 (569–2594) per patient.
format Online
Article
Text
id pubmed-7312207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-73122072020-06-29 Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy Marks, Michael Bell, Lucy C K Jones, Imogen Rampling, Tommy Kranzer, Katharina Morris-Jones, Stephen Logan, Sarah Pollara, Gabriele Clin Infect Dis Brief Reports The OVIVA study demonstrated noninferiority for managing bone and joint infections (BJIs) with oral antibiotics. We report that 79.7% of OPAT patients being treated for BJIs at our center would be eligible for oral antibiotics, saving a median (IQR) 19.5 IV-antibiotic days (8.5–37) and GBP 1234 (569–2594) per patient. Oxford University Press 2020-07-01 2019-10-11 /pmc/articles/PMC7312207/ /pubmed/31603189 http://dx.doi.org/10.1093/cid/ciz991 Text en © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Reports
Marks, Michael
Bell, Lucy C K
Jones, Imogen
Rampling, Tommy
Kranzer, Katharina
Morris-Jones, Stephen
Logan, Sarah
Pollara, Gabriele
Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy
title Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy
title_full Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy
title_fullStr Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy
title_full_unstemmed Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy
title_short Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy
title_sort clinical and economic impact of implementing oviva criteria on patients with bone and joint infections in outpatient parenteral antimicrobial therapy
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312207/
https://www.ncbi.nlm.nih.gov/pubmed/31603189
http://dx.doi.org/10.1093/cid/ciz991
work_keys_str_mv AT marksmichael clinicalandeconomicimpactofimplementingovivacriteriaonpatientswithboneandjointinfectionsinoutpatientparenteralantimicrobialtherapy
AT belllucyck clinicalandeconomicimpactofimplementingovivacriteriaonpatientswithboneandjointinfectionsinoutpatientparenteralantimicrobialtherapy
AT jonesimogen clinicalandeconomicimpactofimplementingovivacriteriaonpatientswithboneandjointinfectionsinoutpatientparenteralantimicrobialtherapy
AT ramplingtommy clinicalandeconomicimpactofimplementingovivacriteriaonpatientswithboneandjointinfectionsinoutpatientparenteralantimicrobialtherapy
AT kranzerkatharina clinicalandeconomicimpactofimplementingovivacriteriaonpatientswithboneandjointinfectionsinoutpatientparenteralantimicrobialtherapy
AT morrisjonesstephen clinicalandeconomicimpactofimplementingovivacriteriaonpatientswithboneandjointinfectionsinoutpatientparenteralantimicrobialtherapy
AT logansarah clinicalandeconomicimpactofimplementingovivacriteriaonpatientswithboneandjointinfectionsinoutpatientparenteralantimicrobialtherapy
AT pollaragabriele clinicalandeconomicimpactofimplementingovivacriteriaonpatientswithboneandjointinfectionsinoutpatientparenteralantimicrobialtherapy

Ejemplares similares